Society ❯Women's Health

Reproductive Rights

Reproductive Rights Reproductive Health Patient Safety Health Policy Reproductive Rights FDA Pharmaceuticals US Foreign Policy Abortion Policy Public Health

HHS Orders FDA Review of Abortion Pill Following Controversial Analysis

The directive comes after a disputed study claimed higher complication rates, despite decades of research affirming mifepristone's safety.

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

Global Maternal Deaths Surge as Aid Cuts Undermine Progress